Multiple growth factors are associated with lesions of atherosclerosis: Specificity or redundancy?

BioEssays

Volumn 18, Issue 4, 1996, Pages 271-282

  Raines, Elaine W ^a   Ross, Russell ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH PROMOTOR;

ARTERIOSCLEROSIS; BIOLOGICAL MODEL; CLASSIFICATION; ENDOTHELIUM; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MONOCYTE; PATHOPHYSIOLOGY; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION;

ARTERIOSCLEROSIS; CYTOKINES; ENDOTHELIUM; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; MODELS, BIOLOGICAL; MONOCYTES; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 0030131145     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.950180405     Document Type: Article

References (70)

1. Ross, R. (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362, 801-809.
2. Sporn, M.B. and Roberts, A.B. (1990). Handbook of Experimental Pharmacology, volumes 95/1 and 95/2: Peptide Growth Factors and Their Receptors I and II. Springer-Verlag, Berlin.
3. Raines, E.W., Rosenfeld, M.E. and Ross, R. (1996). The role of macrophages. In Atherosclerosis and Coronary Artery Disease (ed. V. Fuster, R. Ross and E.J. Topol), pp. 539-555. Lippincott-Raven Publishers, Philadelphia.
4. Friesel, R.E. and Maciag, T. (1995). Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 9, 919-925.
5. Massagué, J. (1990). Transforming growth factor-α. A model for membrane-anchored growth factors. J. Biol. Chem. 265, 21393-21396.
6. Sporn, M.B. and Roberts, A.B. (1992). Autocrine secretion - 10 years later. Ann. Intern. Med. 117, 408-414.
7. Ferns, G.A.A., Raines, E.W., Sprugel, K.H., Motani, A., Reidy, M.A. and Ross, R. (1991). Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253, 1129-1132.
8. Clausell, N., Molossi, S., Sett, S. and Rabinovitch, M. (1994). Blockade of tumor necrosis factor-a in cholesterol-fed rabbits after cardiac transplant inhibits acute coronary artery neointimal formation. Circ. 89, 2768-2779.
9. Raines, E.W. and Ross, R. (1993). Platelet-derived growth factor. In Cytokines, vol. 5: The Biology of PDGF (ed. B. Westermark and C. Sorg), pp. 74-114. S. Karger AG, Basel.
10. Flaumenhaft, R. and Rifkin, D.B. (1992). The extracellular regulation of growth factor action. Mol. Biol. Cell 3, 1057-1065.
11. Webb, D.S.A., Shimizu. Y., Van Seventer, G.A., Shaw, S. and Gerrard, T.L. (1990). LFA-3, CD44 and CD45: Physiologic triggers of human monocyte TNF and IL-1 release. Science 249, 1295-1297.
12. Pober, J.S. and Cotran, R.S. (1990). Cytokines and endothelial cell biology. Physiol. Rev. 70, 427-451.
13. Lukacs, N.W., Strieter, R.M., Einer, V.M., Evanoff, H.L., Burdick, M. and Kunkel, S.L. (1994). Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1 alpha during monocyte-endothelial cell interactions. Blood 83, 1174-1178.
14. Weyrich, A.S., Mclntyre, T.M., McEver, R.P., Prescott, S.M. and Zimmerman, G.A. (1995). Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-a secretion. Signal integration and NF-κB translocation. J. Clin. Invest. 95, 2297-2303.
15. Collins, T. (1993). Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab. Invest. 68, 499-508.
16. Liao, F. andalibi, A., Qiao, J.-H., Allayee, H., Fogelman, A.M. and Lusis, A.J. (1994). Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction and aortic fatty streak formation in mice. J. Clin. Invest. 94, 877-884.
17. 2-macroglobulins. Lab. Invest. 65, 3-14.
18. Rose-John, S. and Heinrich, P.C. (1994). Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300, 281-290.
19. Arend, W.P. (1990). Interteukin-1 receptor antagonist: Discovery, structure and properties. Prog. Growth Factor Res. 2, 193-205.
20. Schweitzer, R., Howes, R., Smith, R., Shito, B.-Z. and Freeman, M. (1995). Inhibition of Drosophila EGF receptor activation by the secreted protein Argos. Nature 376, 699-702.
21. 2-macrogiobulin. a multifunctional binding protein with targeting characteristics. FASEB J. 6, 3345-3353.
22. Clemmons, D.R. (1993). IGF binding proteins and their functions. Mol. Reprod. Dev. 35, 368-374.
23. Flaumenhaft, R. and Rifkin, D.B. (1991). Extracellular matrix regulation of growth factor and protease activity. Curr. Opin. Cell Biol. 3, 817-823.
24. Raines, E.W., Lane, T.F., Iruela-Arispe, M.L., Ross, R. and Sage, E.H. (1992). The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc. Natl Acad Sci.USA 89, 1281-1285.
25. Sporn, M.B. and Roberts, A.B. (1990). The multifunctional nature of peptide growth factors. In Handbook of Experimental Pharmacology: Peptide Growth Factors and their Receptors I (ed. M.B. Sporn and A.B. Roberts), pp. 419-472. Springer-Verlag, Berlin.
26. Gimbrone, M.A., Jr. (1996). Vascular endorhelium in health and disease. In Molecular Cardiovascular Medicine (ed. E. Haber). Scientific American Medicine, New York (in press).
27. Cybulsky, M.I. and Gimbrone, M.A., Jr. (1991). Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788-791.
28. Printseva, O.Y., Peclo, M.M. and Gown A.M. (1992) Various cell types in human atherosclerotic lesions express ICAM-1. Am. J. Pathol. 140, 889-896.
29. Shimizu, Y. et al. (1991). Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Wafure 349, 799-802.
30. Carlos, T.M. and Harlan, J.M. (1994). Leukocyte-endothelial adhesion molecules. Stood 84, 2068-2101.
31. Vaddi, K. and Newton, R.C. (1994). Regulation of monocyte integrin expression by beta-family chemokines. J. Immunol. 153, 4721-4732.
32. Tanaka, K. and Sueishi, K. (1993). The coagulation and fibrinolysis systems and atherosclerosis. Lab. Invest. 69, 5-18.
33. Rosenfeld, M.E. and Ross, R. (1990). Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 10, 680-687.
34. Rekhter, M.D. and Gordon, D. (1995). Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am. J. Pathol. 147, 668-677.
35. Williams, G.T., Smith, C.A, Spooncer, E., Dexter, T.M. and Taylor, D.R. (1990). Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343, 76-79.
36. Munn, D.H., Beall, A.C., Song, D., Wrenn, R.W. and Throckmorton, D.C. (1995). Activation-induced apoptosis in human macrophages: Developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and Interferon γ. J. Exp. Med. 181, 127-136.
37. Han, D.K. et al. (1995). Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am. J. Pathol. 147, 267-277.
38. Geng, V.J. and Libby, P. (1995). Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 ß-converting enzyme. Am. J. Pathol. 147, 251-266.
39. Hogquist, K.A., Nett, M.A., Unanue, E.R. and Chaplin, D.D. (1991). Interleukin 1 is processed and released during apoptosis. Proc. Natl Acad. Sci. USA 88, 8485-8489.
40. Davies, M.J., Richardson, P.D., Woolf, N., Katz, D.R. and Mann, J. (1993). Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage and smooth muscle cell content. Br. Heart J. 69, 377-381.
41. Libby, P. and Hansson, G.K. (1991). Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab. Invest. 64, 5-15.
42. Salonen, J.T. er al. (1992). Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 339, 883-887.
43. Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J.L. and Hansson, G.K. (1995). T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl Acad. Sci. USA 92, 3893-3897.
44. Hajjar, D.P. and Pomerantz, K.B. (1992). Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network. FASEB J. 6, 2933-2941.
45. Wight, T.N. (1996). The vascular extracellular matrix. In Atherosclerosis and Coronary Artery Disease (ed, V. Fuster, R. Ross and E.J. Topol), pp. 421-440. Lippincott-Raven Publishers, Philadelphia.
46. Matrisian, L.M. and Hogan, B.L.M. (1990). Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr Top. Dev. Biol. 24, 219-259.
47. Galis, Z.S., Sukhova, G.K., Lark, M.W. and Libby, P. (1994). Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94, 2493-2503.
48. O'Brien, E.R. et al. (1994). Angiogenesis in human coronary atherosclerotic plaques. Am. J. Pathol. 145, 883-894.
49. Sunderköttar, C., Steinbrink, K., Goebeler, M., Bhardwaj, R. and Sorg, C. (1994). Macrophages and angiogenesis. J. Leukocyte Biol. 55, 410-422.
50. Rollins, B.J., Morrison, E.D. and Stiles, C.D. (1988). Cloning and expression of JE, a gene inducibte by platetet-derived growth factor and whose product has cytokine-like properties. Proc. Natl Acad. Sci. USA 85, 3738-3742.
51. Raines, E.W., Dower, S.K. and Ross, R. (1989). IL-1 milogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA Science 243, 393-396.
52. Battegay, E.J., Raines, E.W., Colbert, T. and Ross, R. (1995). TNF-a stimulation of fibroblast proliferation. Dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. J. Immunol. 154, 6040-6047.
53. Flory, C.M., Jones, M.L., Miller, B.F. and Warren, J.S. (1995) Regulatory roles of tumor necrosis factor-α and interieukin-1 βin monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat. Am. J. Pathol. 146, 450-462.
54. McNamee, H.P., Ingber, D.E. and Schwartz, M.A. (1993). Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown. J. Cell Biol. 121, 673-678.
55. Damsky, C.H. and Werb, Z. (1992). signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr. Opin. Cell Biol. 4, 772-781.
56. Carraway, K.L. and Carraway, C.A.C. (1995). Signaling, mitogenesis and the cytoskeleton: where the action is. BioEssays 17, 171-175.
57. Meredith, J.E. Jr., Fazeli, B. and Schwarte, M.A. (1993). The extracellular matrix as a cell survival factor. Mol. Biol. Cell 2, 953-961.
58. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
59. Matsuno, H., Stassen, J.M., Vermylen, J. and Deckmyn, H. (1994). Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation 90, 2203-2206.
60. Spivak-Kroizman, T. et al. (1994). Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation and cell proliferation. Cell 779, 1015-1024.
61. Schlessinger, J., Lax, I. and Lemmon, M. (1995). Regulation of growth factor activation by proteoglycans: What is the role of the low affinity receptors? Cell 83, 357-360.
62. Doherty, P. and Walsh, F.S. (1994). Signal transduction events underlying neunte outgrowth stimulated by cell adhesion molecules. Neurobiol. 4, 49-55.
63. Kishimoto, T., Taga, T. and Akira, S. (1994). Cytokine signal transduction. Cell 76, 253-262.
64. Taniguchi, T. (1995). Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268, 251-255.
65. Kelvin, D.J. et al . (1993). Chemokines and serpentines: the molecular biology of chemokine receptors. J. Leukocyte Biol. 54, 604-612.
66. Russell, S.M. et al. (1993). Interleukin-2 receptor γ chain: A functional component of the interleukin-4 receptor. Science 262, 1880-1883.
67. Heldin, C.-H. (1995). Dimerization of cell surface receptors in signal transduction. Cell 80, 213-223.
68. Hill, C.S. and Treisman, R. (1995). Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80, 199-211.
69. Levitzki, A. and Gazit, A. (1995). Tyrosine kinase inhibition: an approach to drug development. Science 267, 1782-1788.
70. Resnick, N. and Gimbrone, M.A., Jr. (1995). Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J. 9, 874-882.